A Davos First-Timer on What 4 CEOs Told Us

CVS Wants to Be America’s Healthcare Provider

Weight-Loss Drugs That Actually Work. They Could Be Blockbusters

Buy Progyny Stock. The Small-Cap Could Be a Big Winner By Tackling Infertility.

6 Winners for the New U.S. Economic Reopening.

Medtronic Stock Can Gain 20% as Covid Subsides.

Under Armour Stock Can Continue Its Comeback

Why One Investment Firm Favors Home Depot Over Lowe’s

Gene Therapy Is a Huge Opportunity. It Pays to be Patient.

The Stock Market Is Tanking. These 5 Stocks Are Not.

The S&P 500 Could Struggle This Fall, Market Strategists Say. Buy Quality.

Meet 10 Standout Stocks for Reliable Growth

China Is Making a Big Push Into Digitizing Healthcare

Moderna Stock Is Down 15%. Investors Are Questioning This Year’s Spectacular Surge.

Cathie Wood’s ARK Invest Didn’t Dump All Chinese Stocks. Here’s What It Still Owns.

The FDA Is Under Fire. Here’s How It Affects Investors.

A Biotech Pro Exited Novavax Stock. Here Are Three Stocks It Bought.

Biogen’s Alzheimer’s Drug Opens Up a New Market

Abbott Labs Was a Covid Winner. Why Its Stock Is Getting Crushed.

U.S. Pot Producers Are Growing Like Weeds. Here’s How to Buy In.